Mon 3/18/2019 22:05 ET
DJIA25914.1064.790.25%TELCO168.810.070.04%GOLD1305.554.050.31%Shanghai3109.6513.370.43%
S&P 5002832.9410.480.37%BANKS450.996.041.34%OIL59.380.000.00%BITCOIN3994.315.590.14%
NASDAQ7714.4826.230.34%PHARM576.770.000.00%US/EU1.130.000.00%Futures2843.122.560.09%
Welcome Stranger!  Please sign up or log in to enable additional features.Sign Up | Mail | Log In
Forum - Neovasc - NVCN   

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search | Add NVCN
  
From: kyleLennon (Rep: 0)Date: 08/07/2018 11:07
Forum: Neovasc - Msg #652Thread #674026455 (Rec: 0)
Just yesterday Neovasc resolved potential legal claims that could be brought against the company with the University of Pennsylvania (a.k.a. Penn). The firm has signed a collaboration and licensing agreement with Penn's Gorman Cardiovascular Research Group. Based on the agreement, for a period of time over the next four years Neovasc will pay a fee to Penn. The company will also pay a royalty on Tiara, its cornerstone product, to Penn. This agreement does not impact either Penn's or Neovasc's patent rights, and it also contains buyout clauses which allow a potential acquirer to buy out the royalty obligations.

NVCN: https://www.finstead.com/bite/Neovasc-NVCN-stock-forecast-prediction-august-4-2018

What would you like to do? Message: Endorse | Bookmark | Report AbuseUser kyleLennon: Reward | Watch | IgnoreNVCN: Ignore

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search | Add NVCN
  

TheLion.com | About Us | Agreement & Disclaimer | Privacy | Twitter
© 1999- TheLion.com, Inc.